1. Neuronal Signaling
  2. Beta-secretase

Beta-secretase

Beta-secretase (BACE) is an aspartic-acid protease important in the formation of myelin sheaths in peripheral nerve cells. The transmembrane protein contains two active site aspartate residues in its extracellular protein domain and may function as a dimer. Alzheimer's disease (AD) is caused by aggregates of the amyloid peptide (Abeta), which is generated by cleavage of the Abeta protein precursor (APP) by beta-secretase (BACE-1) followed by gamma-secretase. BACE-1 cleavage is limiting for the production of Abeta, Drugs to block this enzyme (BACE inhibitors) prevent the build up of beta-amyloid and may help slow or stop Alzheimers disease.

Beta-secretase Related Products (9):

Cat. No. Product Name Effect Purity
  • HY-16759
    Verubecestat Inhibitor 99.79%
    MK-8931 is a BACE1 inhibitor. MK-8931 binds significantly to β-secretase.
  • HY-13240
    LY2886721 Inhibitor 99.67%
    LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
  • HY-10472
    LY2811376 Inhibitor 99.67%
    LY2811376 is a BACE1 inhibitor with marked Ab-lowering effects in animal models.
  • HY-N0226A
    Epiberberine chloride Inhibitor 99.60%
    Epiberberine chloride, a natural alkaloid, is a BACE1 inhibitor, which also exhibits inhibition activity on CYP2D6 and aldose reductase, alpha-adrenoceptors, acetylcholinesterase (AChE), butyrylcholinesterase, and b-site amyloid precursor protein cleaving enzyme 1.
  • HY-B0703
    Eslicarbazepine acetate Inhibitor 99.48%
    Eslicarbazepine acetate (BIA 2-093) is an antiepileptic drug.
  • HY-100740
    Lanabecestat Inhibitor 99.76%
    Lanabecestat (AZD3293) is a potent, highly permeable, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM.
  • HY-U00287
    Imidazo[1,2-a]pyridine-2-carboxamide, 6-chloro-N-[6-(phenylmethoxy)-1H-benzimidazol-2-yl]- Inhibitor
    Imidazo[1,2-a]pyridine-2-carboxamide, 6-chloro-N-[6-(phenylmethoxy)-1H-benzimidazol-2-yl]- (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease.
  • HY-13438
    AZD3839 free base Inhibitor 99.89%
    AZD3839 (free base) is a potent and selective BACE1 inhibitor with IC50 of 23.6 uM, about 14-fold selectivity over BACE2, also a β-secretase enzyme inhibitor.
  • HY-N2284
    Sophoflavescenol Inhibitor
    Sophoflavescenol is a prenylated flavonol, which shows great inhibitory activity with IC50 of 13 nM against Phosphodiesterase 5 (PDE5), and also inhibits RLAR, HRAR, AGE, BACE1, AChE and BChE with IC50s of 0.30 μM, 0.17 μM, 17.89 μg/mL, 10.98 μM, 8.37 μM and 8.21 μM, respectively.